10-K: International Media Acquisition Corp. Secures New Merger Target and $300M Equity Line Amidst Nasdaq Delisting and Going Concern Warning

Sentiment:

Annual Report


International Media Acquisition Corp. (IMAQ), a SPAC, has announced a new $1 billion merger agreement with Vietnam Biofuels Development Joint Stock Company and secured a $300 million equity line, following its delisting from Nasdaq and a 'going concern' warning due to repeated failures to complete a business combination.

Delay expectedThe company has repeatedly extended its deadline to complete a business combination, from an initial August 2, 2022, to February 2, 2023, then to August 2, 2023, then to January 2, 2025, and most recently to January 2, 2027.The termination of the proposed business combination with Risee Entertainment Holdings Private Limited on October 25, 2023, after over a year of engagement, represents a significant delay and setback in the company's primary objective.
Capital raiseThe company entered into a Common Stock Purchase Agreement (Equity Line Agreement) with White Lion Capital LLC on April 20, 2025, allowing it to sell up to $300,000,000 (with an option to increase to $500,000,000) in common stock post-business combination.The company issued several unsecured promissory notes to JC Unify Capital (Holdings) Limited (Buyer), with $2,659,713 outstanding as of March 31, 2025, which are convertible into units or common stock upon business combination.A new unsecured promissory note (Promissory Note E) for up to $3,000,000 was issued to Wei-Hua Chang on April 20, 2025, convertible into units upon business combination.The company entered into a VCI Loan Agreement on April 20, 2025, to provide a maximum aggregate amount of $499,900 to the Target Group for transaction expenses, which may be waived upon successful consummation of the transaction.
Worse than expectedThe company received a 'substantial doubt about its ability to continue as a going concern' opinion from its auditor, indicating severe financial uncertainty.The company was delisted from Nasdaq due to its failure to complete a business combination within the required timeframe, leading to a less liquid trading environment on OTC markets.The significant reduction in the Trust Account balance from $230 million to $3.38 million due to high shareholder redemptions indicates a substantial loss of capital and investor confidence.

Summary

  • International Media Acquisition Corp. (IMAQ) is a blank check company (SPAC) that completed its Initial Public Offering (IPO) on August 2, 2021, raising $230 million for a business combination.
  • The company has repeatedly extended its deadline to complete a business combination, most recently to January 2, 2027, through a series of stockholder approvals and sponsor deposits into the trust account.
  • IMAQ's previous proposed business combination with Risee Entertainment Holdings Private Limited (India) for $140 million was terminated on October 25, 2023.
  • On April 3, 2025, IMAQ entered into a new Merger Agreement with VCI Holdings Limited and Vietnam Biofuels Development Joint Stock Company (Target Group), valuing the aggregate consideration at $1 billion, to be paid in 90 million Class A and 10 million Class B ordinary shares.
  • The company was delisted from Nasdaq on August 8, 2024, due to non-compliance with the rule requiring a business combination within 36 months of IPO, and its securities now trade on Over-the-Counter (OTC) markets.
  • As of March 31, 2025, IMAQ reported a net loss of $408,107, an accumulated deficit of $14,852,574, and a working capital deficit of $6,796,725, leading to a 'substantial doubt about its ability to continue as a going concern' by its auditor.
  • The company's cash balance significantly increased to $241,548 as of March 31, 2025, from $1,044 in the prior year, while investments in the Trust Account decreased to $3,380,327 from $11,363,873 due to redemptions.
  • IMAQ has secured an Equity Line Agreement with White Lion Capital LLC on April 20, 2025, allowing it to sell up to $300 million (with an option to increase to $500 million) of common stock post-business combination.
  • The company has also issued several non-interest bearing promissory notes to JC Unify Capital (Holdings) Limited (Buyer) totaling $2,659,713 outstanding as of March 31, 2025, and a new $3 million promissory note to Wei-Hua Chang on April 20, 2025, to fund operations and extension payments.
  • Significant management changes occurred, including the resignation of CEO Shibasish Sarkar and the appointment of Yu-Fang Chiu as CEO, CFO, and Chairman of the Board on March 11, 2025.
  • The company faces various risks related to its foreign target (Vietnam, with potential for China-based targets), including U.S. foreign investment regulations (CFIUS), PRC laws on foreign investment, data security, and the PCAOB's ability to inspect auditors.
  • Outstanding liabilities include $8,050,000 in deferred underwriting fees, contingent on the business combination's completion, and $91,920 in excise tax payable as of March 31, 2025, related to stock redemptions.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative. While the company has secured a new merger target and significant potential financing, its history of repeated extensions, Nasdaq delisting, and the explicit 'going concern' warning indicate severe operational and financial challenges. The new agreements offer a lifeline but do not erase the underlying risks and past failures.

Positives

  • Secured a new Merger Agreement with VCI Holdings Limited and Vietnam Biofuels Development Joint Stock Company for an aggregate consideration of $1 billion, providing a clear path for a business combination.
  • Established an Equity Line Agreement with White Lion Capital LLC for up to $300 million (potentially $500 million) in common stock purchases, offering significant post-combination capital access.
  • Successfully extended the business combination deadline multiple times, now until January 2, 2027, demonstrating shareholder and sponsor commitment to finding a suitable target.
  • Net loss decreased to $408,107 for the year ended March 31, 2025, from $814,487 in the prior year, indicating improved cost management or reduced operational expenses.
  • Cash balance significantly increased to $241,548 as of March 31, 2025, from $1,044 in the prior year, improving immediate liquidity.
  • Management has implemented remediation steps to address material weaknesses in internal control over financial reporting, including increased review layers and consideration of third-party professionals.

Negatives

  • Received a 'substantial doubt about its ability to continue as a going concern' opinion from its auditor due to accumulated deficit, working capital deficit, and the uncertainty of completing a business combination.
  • Delisted from Nasdaq on August 8, 2024, due to failure to complete a business combination within the required timeframe, resulting in trading on less liquid Over-the-Counter (OTC) markets.
  • The previous business combination agreement with Risee Entertainment Holdings Private Limited was terminated, indicating past difficulties in deal execution.
  • Experienced significant redemptions of public shares, reducing the Trust Account balance from $230 million initially to $3,380,327 as of March 31, 2025, which limits the cash available for the business combination.
  • Accumulated deficit increased to $14,852,574 as of March 31, 2025, from $13,993,133 in the prior year.
  • Working capital deficit worsened to $6,796,725 as of March 31, 2025, from $6,348,420 in the prior year.
  • Incurred excise tax payable of $91,920 as of March 31, 2025, related to stock repurchases/redemptions, which cannot be paid from the Trust Account.
  • Reliance on non-interest bearing promissory notes from related parties (JC Unify and Wei-Hua Chang) for funding, which are convertible into equity upon business combination, indicating ongoing financial strain and potential future dilution.
  • Identified material weaknesses in internal control over financial reporting related to complex financial instruments, stock-based compensation, and review of accounts payable and accrued expenses.

Risks

  • Substantial doubt about the ability to continue as a going concern if additional funds are not raised or a business combination is not completed by January 2, 2027.
  • Inability to complete the VCI Business Combination or any alternative business combination due to various factors beyond control, including regulatory approvals, financing, or target willingness.
  • Potential for being deemed an investment company under the Investment Company Act, which could impose burdensome compliance requirements or force liquidation.
  • Exposure to U.S. foreign investment regulations (CFIUS) if pursuing a U.S. target, potentially leading to delays, conditions, or prohibition of the business combination.
  • Significant risks associated with a foreign target, particularly if it were China-based, including limited U.S. investor/regulatory access to information, enforceability of civil liability, and PRC government oversight, antitrust, cybersecurity, and exchange control laws.
  • Uncertainties in the interpretation and application of PRC laws and regulations, which are vague and subject to rapid change, potentially impairing business operations or leading to penalties.
  • Risk of delisting from U.S. exchanges if the PCAOB is unable to inspect or fully investigate the auditor of the combined company for two consecutive years under the Holding Foreign Companies Accountable Act (HFCAA).
  • Increased competition for attractive business combination targets, potentially leading to higher acquisition costs or inability to find a suitable target.
  • Potential for the 1% excise tax on stock repurchases (including redemptions) under the Inflation Reduction Act of 2022, which would be payable by the company and not from the Trust Account.
  • Reliance on management and directors who are not obligated to devote full time to the company and may have conflicts of interest due to other business affiliations.
  • Potential for dilution of equity interest for existing investors if additional shares are issued to complete a business combination or raise financing.
  • Inability to obtain necessary government approvals or complete registrations on a timely basis for capital contributions or foreign loans to PRC subsidiaries, if applicable.

Future Outlook

The company anticipates completing the VCI Business Combination and expects to incur significant costs in pursuit of this plan. Management plans to continue drawing down funds on promissory notes to address liquidity needs and complete the business combination. The company intends to file a registration statement covering shares to be acquired by White Lion Capital LLC within 30 days following the VCI Business Combination closing. The company will remain an emerging growth company until certain revenue or market capitalization thresholds are met or five years post-IPO.

Management Comments

  • Management believes that the operational and transactional experience of its management team and their respective affiliates and related entities, along with developed relationships, will provide a number of potential alternative business combination targets if the VCI Business Combination is not completed.
  • Management has determined that the mandatory liquidation, if a Business Combination does not occur, raises substantial doubt about the Company's ability to continue as a going concern.
  • Management plans to continue to draw down the funds on its promissory notes, repayable promptly on demand and, in any event, no later than the date on which the Company terminates or consummates an initial business combination.

Industry Context

The document highlights the inherent challenges and regulatory scrutiny faced by SPACs, particularly those with extended timelines and international targets. The repeated extensions and eventual Nasdaq delisting reflect the increasing pressure on SPACs to complete mergers within their initial timelines. The shift to OTC markets indicates a loss of mainstream investor access. The detailed discussion of risks related to foreign investment, especially in China (even though the current target is Vietnam), and the impact of U.S. regulations like HFCAA and CFIUS, underscores the complex geopolitical and regulatory landscape for cross-border SPAC transactions. The Inflation Reduction Act's excise tax on redemptions adds another layer of financial consideration for SPACs.

Comparison to Industry Standards

  • IMAQ's repeated extensions and eventual delisting from Nasdaq for failing to complete a business combination within the 36-month timeframe is worse than industry standards, as many SPACs aim to complete a merger within 18-24 months to maintain investor confidence and avoid redemptions.
  • The significant redemptions of public shares (reducing the trust account from $230 million to $3.38 million) are worse than typical SPAC performance, indicating a high level of shareholder dissatisfaction or lack of confidence in previous merger attempts.
  • The 'going concern' warning is a critical red flag, worse than industry standards, as it signals severe financial distress and uncertainty about the company's future viability without a successful business combination.
  • The pursuit of a $1 billion business combination with Vietnam Biofuels Development Joint Stock Company, while ambitious, is within the typical range for SPAC targets, but the company's history of failed deals (e.g., Risee Entertainment) suggests higher execution risk compared to more successful SPACs.
  • The securing of a substantial equity line ($300M-$500M) from White Lion Capital LLC is a positive development, comparable to PIPE (Private Investment in Public Equity) deals seen in other SPAC transactions, providing crucial capital for the post-combination entity.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorPaul F. Pelosi Jr.N/A2023-12-12Resignation pursuant to Securities Purchase Agreement.
DirectorDavid M. TaghioffN/A2023-12-17Resignation pursuant to Securities Purchase Agreement.
DirectorDeepak NayarN/A2023-12-17Resignation pursuant to Securities Purchase Agreement.
DirectorKlaas P. BaksN/A2023-12-17Resignation pursuant to Securities Purchase Agreement.
DirectorSuresh RamamurthiN/A2023-12-17Resignation pursuant to Securities Purchase Agreement.
Class I DirectorN/ASanjay Wadhwa2024-02-13Appointment at Annual Meeting.
Class I DirectorN/AShibasish Sarkar2024-02-13Appointment at Annual Meeting.
Class II DirectorN/AClaudius Tsang2024-02-13Appointment at Annual Meeting.
Class II DirectorN/AYu-Ping Edward Tsai2024-02-13Appointment at Annual Meeting.
Class III DirectorN/ADaung-Yen Lu2024-02-13Appointment at Annual Meeting.
Class III DirectorN/AYao Chin Chen2024-02-13Appointment at Annual Meeting.
Class III DirectorN/AChih Young Hung2024-02-13Appointment at Annual Meeting.
DirectorSanjay WadhwaN/A2024-02-27Resignation.
DirectorChih Young HungN/A2024-06-20Resignation.
Class III Director, Chairman of Audit Committee, Chairman of Compensation CommitteeN/AHsu-Kao Cheng2024-08-06Appointment to fill vacancy.
DirectorDaung-Yen LuN/A2024-07-02Resignation.
Class III Director, Member of Audit Committee, Member of Compensation CommitteeN/ATao-Chou Chang2024-08-06Appointment to fill vacancy.
DirectorYu-Ping TsaiN/A2024-07-02Resignation.
Class II Director, Member of Audit Committee, Member of Compensation CommitteeN/AMing-Hsien Hsu2024-08-06Appointment to fill vacancy.
DirectorClaudius TsangN/A2024-07-04Resignation.
DirectorYao Chin ChenN/A2024-08-06Resignation.
Chief Executive Officer, Class I Director, Chairman of the Board, Principal Accounting and Financial OfficerShibasish SarkarN/A2025-03-11Resignation.
Chief Executive Officer, Chief Financial Officer, Chairman of the BoardN/AYu-Fang Chiu2025-03-11Appointment to fill vacancy.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe board of directors experienced significant turnover and changes in size, reducing from seven to two, then increasing to seven, then reducing to six, then four, and finally settling at four directors with new appointments.Various dates from Dec 2023 to Aug 2024High turnover may indicate instability, but new appointments aim to strengthen governance and align with new strategic direction. The current board consists of one non-independent director (Yu-Fang Chiu) and three independent directors (Ming-Hsien Hsu, Hsu-Kao Cheng, Tao-Chou Chang), maintaining a majority of independent directors as per Nasdaq requirements.
Committee LeadershipHsu-Kao Cheng was appointed Chairman of both the Audit Committee and the Compensation Committee, effective August 6, 2024.2024-08-06Centralizes leadership in key oversight committees under a new independent director, potentially streamlining decision-making and accountability.
Internal Control Over Financial ReportingManagement identified material weaknesses in internal control over financial reporting related to accounting for complex financial instruments, stock-based compensation, and review of accounts payable and accrued expenses.As of 2025-03-31Indicates a risk of financial misstatements. Management has initiated remediation steps, including increased review layers and considering external expertise, which is crucial for improving financial reporting reliability.
Certificate of Incorporation AmendmentStockholders approved an amendment to allow the company to undertake an initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau).2024-12-30Expands the universe of potential target businesses, but also introduces significant regulatory and geopolitical risks associated with China-based entities, as detailed in the risk factors.
Code of Ethics and Insider Trading PoliciesThe company adopted a code of conduct and ethics and insider trading policies and procedures.N/A (adopted prior to filing)Standard corporate governance practices to promote ethical conduct and compliance with securities laws, crucial for a public company.

Legal Proceedings

  • The company is not currently a party to any material litigation or other legal proceedings.
  • The company is subject to a dispute regarding a pending fee of $38,000 with Marcum LLP, but does not anticipate a material adverse effect.

Related Party Transactions

  • The Prior Sponsor paid $25,000 for 5,750,000 Founder Shares, which included shares subject to forfeiture if the over-allotment option was not exercised in full (which it was).
  • The Prior Sponsor transferred Founder Shares to independent directors and a consultant, resulting in recognized compensation expense of $786,848, $141,150, and $423,450 respectively.
  • The Prior Sponsor sold 4,125,000 Founder Shares and 657,675 private placement units to JC Unify Capital (Holdings) Limited (Buyer) for an aggregate purchase price of $1.00.
  • The company has outstanding promissory notes to the Prior Sponsor totaling $2,445,000 as of March 31, 2025, which will be settled by issuing 206,656 shares of common stock upon business combination.
  • The company has outstanding promissory notes to JC Unify Capital (Holdings) Limited (Buyer) totaling $2,659,713 as of March 31, 2025, which are convertible into units or common stock upon business combination.
  • The company owes $656,913 to the Prior Sponsor for term extension fees and other expenses as of March 31, 2025.
  • The company entered into a Loan and Transfer Agreement with Polar Asset Management Partners, allowing the Prior Sponsor to borrow funds for extension payments, with the company issuing shares to Polar as consideration.
  • The company entered into a VCI Loan Agreement on April 20, 2025, to provide a maximum aggregate amount of $499,900 to the Target Group (VCI Holdings Limited and Vietnam Biofuels Development Joint Stock Company) for transaction expenses, which may be waived upon successful consummation.
  • The company issued a Promissory Note E for up to $3,000,000 to Wei-Hua Chang on April 20, 2025, convertible into units upon business combination.
  • Various consulting and service fees to Chardan Capital Markets LLC, Vishwas Joshi (former CFO), Priyanka Agarwal, Ontogeny, and ALMT Legal are to be settled in cash or shares upon the closing of the business combination.

Stakeholder Impact

  • **Shareholders**: Public shareholders have experienced significant dilution through redemptions and the company's delisting from Nasdaq, leading to reduced liquidity and potential loss of investment value. Future share issuances for the business combination and equity line could further dilute existing shareholders. The 'going concern' warning poses a direct threat to their investment.
  • **Prior Sponsor/Buyer (JC Unify)**: These parties have provided significant financing through promissory notes and purchased founder shares for a nominal amount, indicating a strong vested interest in the business combination's success. Their loans are convertible into equity, aligning their interests with the company's long-term success, but also exposing them to the risks.
  • **Employees/Management**: The management team, particularly the new CEO/CFO/Chairman Yu-Fang Chiu, faces the critical task of completing the business combination and addressing the going concern issues. Their compensation and future prospects are tied to the success of the merger.
  • **Creditors**: The company has various outstanding liabilities, including promissory notes and deferred underwriting fees. While the Trust Account is generally protected for public shareholders, the 'going concern' warning raises questions about the company's ability to satisfy all claims if liquidation occurs outside of the Trust Account's protection.
  • **Target Group (VCI Holdings Limited and Vietnam Biofuels Development Joint Stock Company)**: The merger agreement offers a path to public listing in the U.S. and access to capital, but they are exposed to the risks of IMAQ's ability to close the transaction and navigate regulatory hurdles.

Next Steps

  • Complete the VCI Business Combination with VCI Holdings Limited and Vietnam Biofuels Development Joint Stock Company.
  • Form International Media Mini Acquisition Corp. (Purchaser) as a wholly-owned subsidiary.
  • Merge IMAQ with Purchaser (Redomestication Merger), with Purchaser as the surviving entity.
  • Purchaser to acquire 100% of VCI Target Company shares, making it a direct wholly-owned subsidiary.
  • File a registration statement with the SEC covering shares to be acquired by White Lion Capital LLC within 30 days following the VCI Business Combination closing.
  • Continue to draw down funds on promissory notes to cover expenses and working capital needs.
  • Address and remediate identified material weaknesses in internal control over financial reporting.

Key Dates

DateDescription
2021-01-15International Media Acquisition Corp. (IMAQ) incorporated in Delaware.
2021-07-28Registration statement for IPO declared effective; Underwriting Agreement and Warrant Agreement entered.
2021-08-02IPO consummated, generating $200,000,000 from Public Units and $7,144,000 from Private Units.
2021-08-06Underwriters exercised over-allotment option in full, generating additional $30,000,000 from Public Units and $825,000 from Private Units.
2021-08-17Common stock, rights, and warrants began separate trading on Nasdaq.
2022-07-26Prior Sponsor deposited $350,000 into Trust Account to extend deadline to November 2, 2022.
2022-07-27Stockholders approved extension to February 2, 2023; 20,858,105 shares redeemed.
2022-08-10Issued August 2022 Promissory Note to Prior Sponsor for up to $895,000.
2022-08-16Board of directors approved change to fiscal year end from December 31 to March 31; Inflation Reduction Act of 2022 signed into law.
2022-10-22Entered into Stock Purchase Agreement with Risee Entertainment Holdings Private Limited.
2022-10-28Prior Sponsor deposited $350,000 into Trust Account to extend deadline to February 2, 2023.
2022-11-18Issued November 2022 Promissory Note to Prior Sponsor for up to $300,000.
2023-01-24Entered into Loan and Transfer Agreement with Polar Asset Management Partners.
2023-01-27Stockholders approved extension to May 2, 2023 (with monthly extensions to August 2, 2023); 168,777 shares redeemed.
2023-02-03Prior Sponsor deposited $385,541 into Trust Account to extend deadline to May 2, 2023.
2023-02-14Issued February 2023 Promissory Note to Prior Sponsor for up to $500,000.
2023-06-01Prior Sponsor deposited $128,513 into Trust Account for extension.
2023-06-23Prior Sponsor deposited $128,513 into Trust Account for extension.
2023-07-11Prior Sponsor deposited $128,513 into Trust Account for extension.
2023-07-31Stockholders approved extension to August 2, 2024; 63,395 shares redeemed.
2023-10-25Risee Entertainment Holdings Private Limited terminated the Stock Purchase Agreement.
2023-11-10Entered into Securities Purchase Agreement with JC Unify Capital (Holdings) Limited and Prior Sponsor.
2023-12-12Paul F. Pelosi Jr. resigned from the Board of Directors.
2023-12-17David M. Taghioff, Deepak Nayar, Klaas P. Baks, and Suresh Ramamurthi resigned from the Board of Directors.
2024-01-02Stockholders approved extension to January 2, 2025, with $20,000 monthly deposit; 934,193 shares redeemed.
2024-01-31Amended Securities Purchase Agreement; Issued January 2024 Promissory Note (up to $1,300,000) to JC Unify Capital (Holdings) Limited.
2024-02-13Annual Meeting of Stockholders; new Class I, II, and III directors appointed.
2024-02-27Sanjay Wadhwa resigned as Director; Issued Promissory Note B (up to $530,000) and Promissory Note C (up to $470,000) to JC Unify Capital (Holdings) Limited.
2024-06-20Chih Young Hung resigned as Director.
2024-06-28Amendments to JC Unify Prior Notes (January 2024, Promissory Note B, Promissory Note C) to be convertible into units immediately prior to business combination closing.
2024-07-02Daung-Yen Lu and Yu-Ping Tsai resigned as Directors.
2024-07-04Claudius Tsang resigned as Director.
2024-07-09Received Nasdaq Late 10-K Notice.
2024-07-30Received Nasdaq Delisting Notice.
2024-08-06Yao Chin Chen resigned as Director; Hsu-Kao Cheng, Tao-Chou Chang, and Ming-Hsien Hsu appointed as Directors.
2024-08-08Trading suspended on Nasdaq; securities began trading on Over-the-Counter (OTC) markets.
2024-12-30Annual Meeting of Stockholders; stockholders approved extension to January 2, 2027, with $2,000 monthly deposit; 685,836 shares redeemed for $7,919,296.
2025-02-10Outstanding redemption liability of $7,919,296 paid.
2025-03-11Lock-up agreements entered with Prior Sponsor and Ontogeny Capital LTD; Joinder Agreement with JC Unify Capital (Holdings) Limited; Termination of indemnity agreements with Shibasish Sarkar and Vishwas Joshi; Shibasish Sarkar resigned as CEO and Director; Yu-Fang Chiu appointed CEO, CFO, and Chairman.
2025-03-28Issued Promissory Note D (up to $600,000) to JC Unify Capital (Holdings) Limited.
2025-03-31Fiscal year ended.
2025-04-03Entered into Merger Agreement with VCI Holdings Limited and Vietnam Biofuels Development Joint Stock Company.
2025-04-20Entered into Common Stock Purchase Agreement (Equity Line Agreement) with White Lion Capital LLC; Issued Promissory Note E (up to $3,000,000) to Wei-Hua Chang; Entered into VCI Loan Agreement to provide up to $499,900 to Target Group.
2025-08-02Current deadline for business combination (unless further extended).
2027-01-02Extended deadline for business combination (Second Amended Combination Period).
2028Term expiration for Class I directors appointed in December 2024 and Yu-Fang Chiu.

Recommendation

hold

Keywords

SPAC, blank check company, business combination, merger agreement, Vietnam Biofuels Development Joint Stock Company, VCI Holdings Limited, equity line, White Lion Capital LLC, Nasdaq delisting, OTC markets, going concern, promissory notes, trust account, redemptions, SEC filing, 10-K, corporate governance, risk factors, financial reporting, PCAOB, HFCAA, CFIUS, Inflation Reduction Act, related party transactions, Yu-Fang Chiu, Shibasish Sarkar

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.